LEVERKUSEN (dpa-AFX) - Bayer HealthCare (BYR.L, BAYRY.PK, BAYZF.PK) announced the company has successfully concluded the European registration procedure for its new low dose levonorgestrel-releasing intrauterine system. Sweden served as Reference Member State for the Decentralized Procedure to gain EU-wide marketing authorization for the new intrauterine system. Bayer said the Health Authorities of the EU Member States will grant national approvals in the coming weeks and months. Bayer plans first launches of the product in the EU in the second quarter of 2013.
The long-term contraceptive is placed in the uterus for the prevention of pregnancy for up to three years. Compared to oral contraceptives the new IUS is a contraceptive option for women that do not want to take a pill every day.
Once approved, Bayer HealthCare plans to market the new intrauterine system under the brand name 'Jaydess' in the EU.
Copyright RTT News/dpa-AFX
© 2012 AFX News
